• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSZ1900022 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JYSZ1900021 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JYSZ1900020 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JYSZ1900019 谷赖胰岛素注射液 insulin glulisine Injection Biological Products License Renew 2019-05-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-10-28 view
JYSZ0800002 甘精胰岛素注射液 insulin glargine Injection Biological Products License Renew 2008-01-25 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2008-12-22 view
JYSZ0800001 甘精胰岛素注射液 insulin glargine Injection Biological Products License Renew 2008-01-25 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2008-12-22 view
JYSF1900021 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2019-12-03 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-12-19 view
JYSB2100068 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2021-03-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH In Review 2021-03-10 view
JYSB2100067 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2021-03-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH In Review 2021-03-10 view
JYSB2100066 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2021-03-10 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH In Review 2021-03-10 view
JYSB2000324 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2020-06-29 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2020-07-01 view
JYSB2000323 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2020-06-29 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2020-07-01 view
JYSB2000322 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2020-06-29 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2020-07-01 view
JYSB1900331 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2019-11-26 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Filed 2019-12-10 view
JYSB1700217 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-21 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-04-25 view
JYSB1700216 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-01 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-04-25 view
JYSB1700215 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2019-04-25 view
JYSB1700214 谷赖胰岛素注射液 insulin glulisine Injection Biological Products Supplementary Application 2017-12-28 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2018-12-25 view
JYSB1600203 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2016-09-30 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2016-12-20 view
JYSB1600202 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2016-10-20 Sanofi-Aventis Deutschland GmbH Sanofi-Aventis Deutschland GmbH Certificate Issued 2017-03-27 view